The role of novel risk-scoring systems in predicting the efficacy of immunotherapy

Background. Metastatic non-small cell lung cancer (mNSCLC) remains a significant oncological challenge despite major advancements in treatment with immune checkpoint inhibitors (ICIs). However, some patients resist ICIs, highlighting the need for novel risk-scoring systems to predict immunotherapy e...

Full description

Saved in:
Bibliographic Details
Main Author: Yu.V. Moskalenko
Format: Article
Language:English
Published: V. N. Karazin Kharkiv National University 2025-02-01
Series:Journal of V. N. Karazin Kharkiv National University: Series Medicine
Subjects:
Online Access:https://ukrmedsci.com/index.php/visnyk/article/view/139
Tags: Add Tag
No Tags, Be the first to tag this record!